Impact of plasma-protein binding on receptor occupancy: An analytical description

被引:24
作者
Peletier, Lambertus A. [1 ]
Benson, Neil [2 ]
van der Graaf, Piet H. [2 ]
机构
[1] Leiden Univ, Math Inst, NL-2300 RA Leiden, Netherlands
[2] Pfizer Global Res & Dev, Dept Pharmacokinet Dynam & Metab, Sandwich CT13 9NJ, Kent, England
关键词
Plasma-protein binding; Receptor occupancy; Modelling complex systems behaviours; Time scales; Analytical descriptions; SERUM-ALBUMIN BINDING; DRUGS; KINETICS; VOLUME;
D O I
10.1016/j.jtbi.2008.09.014
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this paper we analyse the dynamics of an inhibitor I which can either bind to a receptor R or to a plasma protein P. Assuming typical association and dissociation rates, we find that after an initial dose of inhibitor, there are three time scales: a short one, measured in fractions of seconds, in which the inhibitor concentration and the plasma-protein complex jump to quasi-stationary values, a medium one, measured in seconds in which the receptor complex rises to an equilibrium value and a large one, measured in hours in which the inhibitor-receptor complex slowly drops down to zero. We show that the average receptor occupancy, the pharmacologically relevant quantity, taken over, say, 24 h reaches a maximal value for a specific value of the plasma-protein binding constant. Potentially, understanding and exploiting this optimum could be of great interest to those involved in drug discovery and development. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:253 / 262
页数:10
相关论文
共 23 条
[1]   Changes in plasma protein binding have little clinical relevance [J].
Benet, LZ ;
Hoener, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :115-121
[2]   Opinion - Drug-target residence time and its implications for lead optimization [J].
Copeland, Robert A. ;
Pompliano, David L. ;
Meek, Thomas D. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :730-739
[3]  
Ericsson H, 2004, DRUG METAB DISPOS, V32, P923
[4]   Alpha-1-acid glycoprotein [J].
Fournier, T ;
Medjoubi-N, N ;
Porquet, D .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1482 (1-2) :157-171
[5]   Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels [J].
Frostell-Karlsson, Å ;
Remaeus, A ;
Roos, H ;
Andersson, K ;
Borg, P ;
Hämäläinen, M ;
Karlsson, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (10) :1986-1992
[6]   Unexpected relationship between plasma protein binding and the pharmacodynamics of 2-NAP, a CCK1-receptor antagonist [J].
Gerskowitch, V. P. ;
Hodge, J. ;
Hull, R. A. D. ;
Shankley, N. P. ;
Kalindjian, S. B. ;
McEwen, J. ;
Black, J. W. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) :618-622
[7]   Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning [J].
Hollosy, Ferenc ;
Valko, Klara ;
Hersey, Anne ;
Nunhuck, Shenaz ;
Keri, Gyorgy ;
Bevan, Chris .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :6958-6971
[8]   Human alpha-1-glycoprotein and its interactions with drugs [J].
Israili, ZH ;
Dayton, PG .
DRUG METABOLISM REVIEWS, 2001, 33 (02) :161-235
[9]   PLASMA AND TISSUE PROTEIN-BINDING OF DRUGS IN PHARMACOKINETICS [J].
JUSKO, WJ ;
GRETCH, M .
DRUG METABOLISM REVIEWS, 1976, 5 (01) :43-140
[10]  
Kenakin T., 2004, A pharmacology primer - Theory, application and methods